Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Five-Year, Multicenter, Commercial Label Safety Study of TRAVATAN® 0.004% in Patients With TRAVATAN-Induced Iris Pigmentation Changes

NCT00047554 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00047554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00047554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Five-Year, Multicenter, Commercial Label Safety Study of TRAVATAN® 0.004% in Patients With TRAVATAN-Induced Iris Pigmentation Changes
Lead sponsor
Alcon Research
Phase
Observational
Overall status
Terminated
Start date
May 31, 2003
Completion date
June 30, 2012
Enrollment
336 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open-angle glaucoma